Ajanta Pharma Limited (AJANTPHARM.BO)
- Previous Close
2,140.20 - Open
2,159.95 - Bid --
- Ask --
- Day's Range
2,120.85 - 2,280.00 - 52 Week Range
1,240.55 - 2,355.05 - Volume
6,466 - Avg. Volume
2,838 - Market Cap (intraday)
277.103B - Beta (5Y Monthly) 0.02
- PE Ratio (TTM)
37.73 - EPS (TTM)
58.32 - Earnings Date May 2, 2024
- Forward Dividend & Yield 36.00 (1.64%)
- Ex-Dividend Date Feb 8, 2024
- 1y Target Est
1,315.86
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as antimalarial, cardiology, ophthalmology, dermatology, pain management, gastroenterology, antihistamine, respiratory, diabetes areas. It also provides tablets, capsules, powder, liquid, jelly, ointments, sterile eye drops, active pharma ingredient. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
www.ajantapharma.com7,713
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: AJANTPHARM.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AJANTPHARM.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AJANTPHARM.BO
Valuation Measures
Market Cap
277.10B
Enterprise Value
272.62B
Trailing P/E
37.80
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.96
Price/Book (mrq)
7.96
Enterprise Value/Revenue
6.81
Enterprise Value/EBITDA
24.15
Financial Highlights
Profitability and Income Statement
Profit Margin
18.23%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
40.36B
Net Income Avi to Common (ttm)
7.36B
Diluted EPS (ttm)
58.32
Balance Sheet and Cash Flow
Total Cash (mrq)
4.76B
Total Debt/Equity (mrq)
0.95%
Levered Free Cash Flow (ttm)
--
Research Analysis: AJANTPHARM.BO
Company Insights: AJANTPHARM.BO
AJANTPHARM.BO does not have Company Insights